Phase I Study of Oral Abexinostat, a Histone Deacetylase Inhibitor, in Combination with Doxorubicin in Patients with Metastatic Sarcoma

INTRODUCTION: Several inhibitors of histone deacetylase have been shown to enhance chemotherapy induced apoptosis and reduce sarcoma tumor volume in preclinical models. We sought to determine the MTD, PK/PD, safety and toxicity of the histone deacetylase inhibitor (HDACi) abexinostat (PCI-24781) whe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Choy, Edwin, Flamand, Yael, Balasubramanian, Sriram, Butrynski, James E., Harmon, David C., George, Suzanne, Cote, Gregory M., Wagner, Andrew J., Morgan, Jeffrey A., Sirisawad, Mint, Mani, Chitra, Hornicek, Francis J., Duan, Zhenfeng, Demetri, George D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393337/
https://ncbi.nlm.nih.gov/pubmed/25536954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29175
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares